Xin Tian
Impact in
-
- MicroRNA in disease regulation
- Finance top 10%
- Healthcare Systems and Reforms
Papers in
-
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 4
- Oncology 7
- Cancer-related Molecular Pathways 3
- Co-authors
- Guangjun Nie (3 shared papers)Motao Zhu (3 shared papers)Yuliang Zhao (2 shared papers)Yanhua Tian (2 shared papers)Yaojiang Shi (1 shared paper)Sean Sylvia (1 shared paper)Alexis Medina (1 shared paper)Scott Rozelle (1 shared paper)
- Journals
- European Journal of Pharmacology (2 papers)Drug Delivery and Translational Research (1 paper)Colloids and Surfaces A Physicochemical and Engineering Aspects (1 paper)Health Policy and Planning (1 paper)Medicinal Chemistry Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xin Tian
46 papers receiving 821 citations
Peers
Comparison fields: 5 of 112
- Cancer Research 114
- Finance 68
- Molecular Biology 360
- Immunology 101
- Cardiology and Cardiovascular Medicine 96
Countries citing papers authored by Xin Tian
This map shows the geographic impact of Xin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Tian more than expected).
Fields of papers citing papers by Xin Tian
This network shows the impact of papers produced by Xin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Tian. The network helps show where Xin Tian may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 120 | |
| 2 | 2009 | 84 | |
| 3 | 2012 | 77 | |
| 4 | 2022 | 44 | |
| 5 | 2012 | 40 | |
| 6 | 2017 | 35 | |
| 7 | 2018 | 34 | |
| 8 | 2019 | 29 | |
| 9 | 2022 | 28 | |
| 10 | 2019 | 26 | |
| 11 | 2011 | 23 | |
| 12 | 2018 | 23 | |
| 13 | 2018 | 22 | |
| 14 | 2012 | 21 | |
| 15 | 2022 | 20 | |
| 16 | 2018 | 18 | |
| 17 | 2021 | 16 | |
| 18 | 2018 | 16 | |
| 19 | 2000 | 15 | |
| 20 | 1999 | 14 |
About Xin Tian
Xin Tian is a scholar working on Molecular Biology, Oncology, Cancer Research, Physiology and Immunology, having authored 47 papers that have together received 832 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Extracellular vesicles in disease (4 papers), Pulmonary Hypertension Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers), Nitric Oxide and Endothelin Effects (3 papers), MicroRNA in disease regulation (3 papers), Nanoplatforms for cancer theranostics (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (114 citations), Finance (68 citations), Molecular Biology (360 citations), Immunology (101 citations) and Cardiology and Cardiovascular Medicine (96 citations). Xin Tian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guangjun Nie, Motao Zhu, Yuliang Zhao, Yanhua Tian, Yaojiang Shi, Sean Sylvia, Alexis Medina, Scott Rozelle, Hao Xue and Qingmei Liu. Their work appears in journals such as European Journal of Pharmacology, Drug Delivery and Translational Research, Colloids and Surfaces A Physicochemical and Engineering Aspects, Health Policy and Planning and Medicinal Chemistry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.